Rapport Therapeutics, Inc. · NASDAQ:RAPP

Ceesay Abraham sold 8,210 Rapport Therapeutics, Inc. shares (Form 4)

Traded Sep 8, 2026 · Filed Sep 9, 2026

On Sep 8, 2026, Ceesay Abraham (Director, Chief Executive Officer) sold 8,210 Rapport Therapeutics, Inc. shares at an average US$45.62 for US$375K under a trading plan, leaving 458,977 shares. Filed Sep 9, 2026 (Form 4).

Sold
8,210 shares
Price
US$45.62 average (US$45.56 to US$46.01)
Value
US$375K
Holding after
458,977 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 8, 2026Common StockSale7,141US$45.56460,046Direct
Sep 8, 2026Common StockSale1,069US$46.01458,977Direct

Source

View original at SEC

Related